USE OF DIFFERENTIATION-INDUCING AGENTS IN THE MYELODYSPLASTIC SYNDROME AND ACUTE NON-LYMPHOCYTIC LEUKEMIA

[1] BRENTMAN TR, 1980, P NATL ACAD SCI USA, V77, P2936

[2] DAENEN S, 1986, BLOOD, V67, P559

[3] DEGOS L, 1985, SEMIN ONCOL, V12, P196

[4] FLYNN PJ, 1983, BLOOD, V62, P1211

[5] FONTANA JA, 1986, CANCER-AM CANCER SOC, V57, P209, DOI 10.1002/1097-0142(19860115)57:2<209::AID-CNCR2820570204>3.0.CO

[6] 2-K

[7] GOLD EJ, 1983, CANCER TREAT REP, V67, P981

[8] GREENBERG BR, 1985, CANCER TREAT REP, V69, P1369

[9] GREENBERG PL, 1983, BLOOD, V61, P1035

[10] HOELZER D, 1985, SEMIN ONCOL, V12, P208

[1] BRENTMAN TR, 1980, P NATL ACAD SCI USA, V77, P2936

[2] DAENEN S, 1986, BLOOD, V67, P559

[3] DEGOS L, 1985, SEMIN ONCOL, V12, P196

[4] FLYNN PJ, 1983, BLOOD, V62, P1211

[5] FONTANA JA, 1986, CANCER-AM CANCER SOC, V57, P209, DOI 10.1002/1097-0142(19860115)57:2<209::AID-CNCR2820570204>3.0.CO

[6] 2-K

[7] GOLD EJ, 1983, CANCER TREAT REP, V67, P981

[8] GREENBERG BR, 1985, CANCER TREAT REP, V69, P1369

[9] GREENBERG PL, 1983, BLOOD, V61, P1035

[10] HOELZER D, 1985, SEMIN ONCOL, V12, P208